| Literature DB >> 15961103 |
Joan L Arolas1, Grzegorz M Popowicz, Julia Lorenzo, Christian P Sommerhoff, Robert Huber, Francesc X Aviles, Tad A Holak.
Abstract
The tick carboxypeptidase inhibitor (TCI) is a proteinaceous inhibitor of metallo-carboxypeptidases present in the blood-sucking tick Rhipicephalus bursa. The three-dimensional crystal structures of recombinant TCI bound to bovine carboxypeptidase A and to human carboxypeptidase B have been determined and refined at 1.7 A and at 2.0 A resolution, respectively. TCI consists of two domains that are structurally similar despite the low degree of sequence homology. The domains, each consisting of a short alpha-helix followed by a small twisted antiparallel beta-sheet, show a high level of structural homology to proteins of the beta-defensin-fold family. TCI anchors to the surface of mammalian carboxypeptidases in a double-headed manner not previously seen for carboxypeptidase inhibitors: the last three carboxy-terminal amino acid residues interact with the active site of the enzyme in a way that mimics substrate binding, and the N-terminal domain binds to an exosite distinct from the active-site groove. The structures of these complexes should prove valuable in the applications of TCI as a thrombolytic drug and as a basis for the design of novel bivalent carboxypeptidase inhibitors.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15961103 DOI: 10.1016/j.jmb.2005.05.015
Source DB: PubMed Journal: J Mol Biol ISSN: 0022-2836 Impact factor: 5.469